← Back to Search

Behavioural Intervention

High Intensity Dysphagia Therapy for Stroke

N/A
Waitlist Available
Led By Alba M Azola, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ischemic Stroke
Identified to have acute dysphagia s/p ischemic stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 weeks
Awards & highlights

Study Summary

This trial tests a standard therapy to help stroke survivors recover their swallowing ability.

Who is the study for?
This trial is for adults aged 18-99 who have had an ischemic stroke and are experiencing acute swallowing difficulties (dysphagia) as a result. Participants must be able to follow simple instructions for swallowing therapy. It's not suitable for those under 18 or over 100, with other types of strokes, previous dysphagia, or advanced progressive neurological diseases.Check my eligibility
What is being tested?
The study is testing high intensity dysphagia therapy to establish a standardized treatment protocol that could improve recovery from swallowing disorders following an ischemic stroke.See study design
What are the potential side effects?
While the specific side effects are not detailed here, high intensity therapies can sometimes lead to fatigue or discomfort in the affected muscles due to the rigorous nature of exercises involved.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had an ischemic stroke.
Select...
I have sudden difficulty swallowing after a stroke.
Select...
I am between 18 and 99 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with improved swallowing as assessed by the Functional Oral Intake Scale (FOIS)
Number of participants with improved swallowing as assessed by the improved Penetration Aspiration Scale (PAS)
Number of participants with perceived improvements in swallowing

Trial Design

1Treatment groups
Experimental Treatment
Group I: Active Participants in high intensity dysphagia therapyExperimental Treatment1 Intervention
Participants with acute dysphagia who will receive high intensity dysphagia therapy during stay in inpatient rehab facility

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,259 Previous Clinical Trials
14,820,593 Total Patients Enrolled
1 Trials studying Dysphagia
Alba M Azola, MDPrincipal InvestigatorJohns Hopkins University

Media Library

High Intensity Dysphagia Rehab (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05970406 — N/A
Dysphagia Research Study Groups: Active Participants in high intensity dysphagia therapy
Dysphagia Clinical Trial 2023: High Intensity Dysphagia Rehab Highlights & Side Effects. Trial Name: NCT05970406 — N/A
High Intensity Dysphagia Rehab (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05970406 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical experiment open to participants who are younger than 80 years old?

"This clinical study is open to participants aged 18 and above, up to a maximum of 99 years old."

Answered by AI

Who qualifies to participate in this investigation?

"To gain admittance to this clinical research, applicants must have dysphagia and be aged 18-99. Presently, 60 participants are being recruited for the study."

Answered by AI

Is enrollment for this research endeavor still open?

"Per the clinicaltrials.gov website, this study is not presently recruiting patients; it was initially posted on September 1st 2023 and last updated on July 24th 2023. Nonetheless, there are 1196 other medical trials that participants can explore for their potential involvement."

Answered by AI
~40 spots leftby Nov 2026